GlassScriptPhysician profile
Jasmin Philip
NPI 1609261023
$2,078.60
in general payments reported to CMS, 2019-2025
17 companies · $1,344 in 2025
The $1,344 reported for 2025 was more than what 89% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $155 · 2024: $579 · 2025: $1,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454 · Consulting Fee: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.60 |
| Consulting Fee | $625.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $788.54 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $381.44 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Celgene Corporation | $152.20 | 2023-2024 | Reblozyl, Onureg |
| Genmab U.S., INC. | $124.69 | 2025 | Tivdak |
| Verastem, INC. | $124.49 | 2025 | Avmapki Fakzynja Co-Pack |
| Gilead Sciences, INC. | $102.60 | 2024 | Trodelvy |
| Syndax Pharmaceuticals, INC. | $75.14 | 2025 | |
| Eisai INC. | $64.09 | 2023 | |
| Janssen Biotech, INC. | $54.54 | 2025 | Darzalex, Talvey, Erleada |
| Pharmaessentia USA Corporation | $45.43 | 2024-2025 | Besremi |
| Beigene USA, INC. | $42.09 | 2024 | Brukinsa |
| Glaxosmithkline, LLC. | $23.36 | 2024 | Ojjaara |
| Incyte Corporation | $22.69 | 2025 | Zynyz |
| Mirati Therapeutics, INC. | $22.21 | 2024 | Krazati |
| Lilly USA, LLC | $18.71 | 2025 | Jaypirca, Verzenio |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $18.21 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.17 | 2025 | Lynozyfic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmin Philip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.